These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 15066291)

  • 1. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.
    Mangili P; Stea L; Cattani F; Lappi S; Giglioli F; Calamia E; Ziglio F; Martinelli R; Longobardi B
    Radiother Oncol; 2004 Apr; 71(1):13-21. PubMed ID: 15066291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
    Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
    Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
    Pickett B; Pouliot J
    Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idealized line source configuration for permanent 125I prostate implants.
    Leclerc G; Lavallée MC; Tubic D; Métivier J; Vigneault E; Beaulieu L
    Radiother Oncol; 2004 Aug; 72(2):213-20. PubMed ID: 15297139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of CT- and radiograph-based post-implant dosimetry for transperineal 125I prostate brachytherapy using single seeds and a commercial treatment-planning software.
    Siebert FA; Kohr P; Kovács G
    Strahlenther Onkol; 2006 Feb; 182(2):96-101. PubMed ID: 16447016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive I-125 multi-seed comparison for prostate brachytherapy: dosimetry and visibility analysis.
    Al-Qaisieh B; Smith DW; Brearley E; St Clair S; Bownes P
    Radiother Oncol; 2007 Aug; 84(2):140-7. PubMed ID: 17588696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-volume conundrum for response of prostate cancer to brachytherapy: summary dosimetric measures and their relationship to tumor control probability.
    D'Souza WD; Thames HD; Kuban DA
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1540-8. PubMed ID: 15050335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of MRI- and CT-based post-implant dosimetric analysis of transperineal interstitial permanent prostate brachytherapy.
    Prete JJ; Prestidge BR; Bice WS; Dubois DF; Hotchkiss LA
    Radiat Oncol Investig; 1998; 6(2):90-6. PubMed ID: 9572685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
    Su Y; Davis BJ; Furutani KM; Herman MG; Robb RA
    Phys Med Biol; 2007 Jun; 52(11):3105-19. PubMed ID: 17505092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The robustness of dose distributions to displacement and migration of 125I permanent seed implants over a wide range of seed number, activity, and designs.
    Beaulieu L; Archambault L; Aubin S; Oral E; Taschereau R; Pouliot J
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1298-308. PubMed ID: 15001275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate brachytherapy post-implant dosimetry: a comparison between higher and lower source density.
    Thomas CW; Kruk A; McGahan CE; Spadinger I; Morris WJ
    Radiother Oncol; 2007 Apr; 83(1):18-24. PubMed ID: 17368844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications.
    Zelefsky MJ; Yamada Y; Cohen GN; Sharma N; Shippy AM; Fridman D; Zaider M
    Radiother Oncol; 2007 Aug; 84(2):185-9. PubMed ID: 17692978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate post-implant dosimetry: interobserver variability in seed localisation, contouring and fusion.
    De Brabandere M; Hoskin P; Haustermans K; Van den Heuvel F; Siebert FA
    Radiother Oncol; 2012 Aug; 104(2):192-8. PubMed ID: 22857857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric quality endpoints for low-dose-rate prostate brachytherapy using biological effective dose (BED) vs. conventional dose.
    Singh R; Al-Hallaq H; Pelizzari CA; Zagaja GP; Chen A; Jani AB
    Med Dosim; 2003; 28(4):255-9. PubMed ID: 14684190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of volume and DVH parameters determined with different brachytherapy treatment planning systems.
    Kirisits C; Siebert FA; Baltas D; De Brabandere M; Hellebust TP; Berger D; Venselaar J
    Radiother Oncol; 2007 Sep; 84(3):290-7. PubMed ID: 17698231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a dynamic real-time intraoperative permanent prostate brachytherapy methodology.
    Potters L; Calguaru E; Thornton KB; Jackson T; Huang D
    Brachytherapy; 2003; 2(3):172-80. PubMed ID: 15062140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A software system for interventional magnetic resonance image-guided prostate brachytherapy.
    Kooy HM; Cormack RA; Mathiowitz G; Tempany C; D'Amico AV
    Comput Aided Surg; 2000; 5(6):401-13. PubMed ID: 11295853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the MIM Symphony treatment planning system for low-dose-rate- prostate brachytherapy.
    Dhanesar SK; Lim TY; Du W; Bruno TL; Frank SJ; Kudchadker RJ
    J Appl Clin Med Phys; 2015 Sep; 16(5):62–75. PubMed ID: 26699290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry.
    Van Gellekom MP; Moerland MA; Van Vulpen M; Wijrdeman HK; Battermann JJ
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):772-80. PubMed ID: 15964707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.